Alembic Pharmaceuticals gets FDA final approval for ulcerative colitis generic drug
Alembic Pharmaceuticals said that it has secured final approval for its abbreviated new drug application (ANDA) for Mesalamine Extended-Release Capsules USP, 0.375 g from the ... Read More